Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates

Archives of Ophthalmology

Volumn 123, Issue 4, 2005, Pages 500-506

  Le Meur, Guylène ^a   Weber, Michel ^b   Péréon, Yann ^c   Mendes Madeira, Alexandra ^a   Nivard, Delphine ^a   Deschamps, Jack Yves ^d   Mouiller, Philippe ^a   Rolling, Fabienne ^a,d  

^a INSERM   (France)

^b Service d'Ophtalmologie   (France)

^c Lab d'Explorations Fonctionnelles   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; PHENYLEPHRINE; TROPICAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ELECTRORETINOGRAPHY; EYE PHOTOGRAPHY; FLUORESCENCE; FOLLOW UP; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; LONG TERM CARE; MACACA; NONHUMAN; POSTOPERATIVE PERIOD; PRIMATE; PRIORITY JOURNAL; RETINA; RETINA ANGIOGRAPHY; SAFETY; TRANSGENE; VIRUS RECOMBINANT; VITRECTOMY; ADENO ASSOCIATED VIRUS; ANIMAL; DEFECTIVE VIRUS; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; POSTOPERATIVE CARE;

ANIMALS; DEFECTIVE VIRUSES; DEPENDOVIRUS; DOGS; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MACACA FASCICULARIS; POSTOPERATIVE CARE; RETINA; SAFETY; TRANSGENES;

EID: 16844385431     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.4.500     Document Type: Article

References (38)

1. Snyder RO. Adeno-associated virus-mediated gene delivery. J Gene Med. 1999;1:166-175.
2. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther. 2000;7:24-30.
3. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM. Gene therapy vectors based on adeno-associated virus type 1. J Virol. 1999;73:3994-4003.
4. Muramatsu S, Mizukami H, Young NS, Brown KE. Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology. 1996;221:208-217.
5. Chiorini JA, Yang L, Liu Y, Safer B, Kotin RM. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol. 1997;71:6823-6833.
6. Chiorini JA, Kim F, Yang L, Kotin RM. Cloning and characterization of adeno-associated virus type 5. J Virol. 1999;73:1309-1319.
7. Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (MV) serotypes otherthan MV type 2. J Virol. 1998;72:309-319.
8. Gao GP, Lu F, Sanmiguel JC, et al. Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap. Mol Ther. 2002;5:644-649.
9. Ali RR, Reichel MB, Thrasher AJ, et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet. 1996;5:591-594.
10. Ali RR, Reichel MB, De Alwis M, et al. Adeno-associated virus gene transfer to mouse retina. Hum Gene Ther. 1998;9:81-86.
11. Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A. 1999;96:9920-9925.
12. Dudus L, Anand V, Acland GM, et al. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res. 1999;39:2545-2553.
13. Lotery AJ, Yang GS, Mullins RF, et al. Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther. 2003;14:1663-1671.
14. Liang FQ, Aleman TS, Oejneka NS, et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther. 2001;4:461-472.
15. Guy J, Qi X, Muzyczka N, Hauswirth WW. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol. 1999;117:929-937.
16. Folliot S, Briot D, Conrath H, et al. Sustained tetracycline-regulated transgene expression in vivo in rat ganglion cells using a single type 2 adeno-associated viral vector. J Gene Med. 2003;5:493-501.
17. Auricchio A, Kobinger G, Anand V, et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet. 2001;10:3075-3081.
18. Weber M, Rabinowitz J, Provost N, et al. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Mol Ther. 2003;7:774-781.
19. Raisler BJ, Berns KI, Grant MB, Beliaev D, Hauswirth WW. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proc Natl Acad Sci U S A. 2002;99:8909-8914.
20. Bainbridge JW, Mistry A, De Alwis M, et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther, 2002;9:320-326.
21. Mori K, Gehlbach P, Yamamoto S, et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1994-2000.
22. Ali RR, Sarra GM, Stephens C, et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet. 2000;25:306-310.
23. Smith AJ, Schlichtenbrede FC, Tschernutter M, Bainbridge JW, Thrasher AJ, Ali RR. AAV-mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. Mol Ther. 2003;8:188-195.
24. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
25. Narfstrom K, Katz ML, Bragadottir R, et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci. 2003;44:1663-1672.
26. Yang GS, Schmidt M, Van Z, et al. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol. 2002;76:7651-7660.
27. Grimm D, Kleinschmidt JA. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther. 1999;10:2445-2450.
28. Rabinowitz JE, Rolling F, Li C, et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol. 2002;76:791-801.
29. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol. 2001;75:6884-6893.
30. Salvetti A, Orève S, Chadeuf G, et al. Factors influencing recombinant adeno-associated virus production. Hum Gene Ther. 1998;9:695-706.
31. Marmor MF, Zrenner E. Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol. 1998;97:143-156.
32. Schatz H. Fluorescein angiography: basic principles and interpretation. In: Ryan SJ, ed. Retina, 2nd ed. St Louis, Mo: Mosby-Year Book, Inc; 1994;911-984.
33. Guyer D, Yannuzzi L, Slakter J, Sorenson J, Orlock D. Diagnostic indocyanine green videoangiography. In: Ryan SJ, ed. Retina. 2nd ed. St Louis, Mo: Mosby-Year Book, Inc; 1994:985-996.
34. Bainbridge JW, Mistry A, Schlichtenbrede FC, et al. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina. Gene Ther. 2003;10:1336-1344.
35. Rao N. Inflammations and infections of the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithelium. New York, NY: Oxford University Press; 1998:528-541.
36. Seeliger MW, Narfstrom K. Functional assessment of the regional distribution of disease in a cat model of hereditary retinal degeneration. Invest Ophihalmol Vis Sci. 2000;41:1998-2005.
37. Daly TM, Ohlemiller KK, Roberts MS, Vogler CA, Sands MS. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther. 2001;8:1291-1298.
38. Donsante A, Vogler CA, Muzyczka N, et al. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther. 2001;8:1343-1346.